Central Nervous System Disorders is under clinical development by Neuroplast and currently in Phase I for Amyotrophic Lateral Sclerosis.

Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Amyotrophic Lateral Sclerosis.

The 4th annual Rally 4 Nally polar plunge took place on Saturday to raise awareness and donations for ALS. Rally 4 Nally, is ...

High levels of cholesterol are a risk factor for atherosclerosis and cardiovascular diseases, which can lead to ...

Amyotrophic lateral sclerosis (ALS) is a serious and usually fatal neurodegenerative disorder in which motor neurons deteriorate and die. | Genetics And Genomics ...

Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder that affects specific nerve cells in the spinal cord known as motor neurons. Symptoms involve issues with swallowing and speech ...

It can take twice as long for people to receive an amyotrophic lateral sclerosis (ALS) diagnosis if they are seen in a general neurology clinic compared to a specialist clinic, […] ...

After being diagnosed with ALS in 2022, Brooke Eby could have turned inward. Instead, she opened up — and found a fan base ...

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Friday morning. The firm issued a sell rating on the biopharmaceutical ...

Therapeutics announced that it has entered into a binding term sheet with a leading global pharmaceutical company to advance ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons. The average life ...